Health ❯ Healthcare ❯ Clinical Trials

Phase II Trials

Patient Outcomes Randomized Controlled Trials Weight Loss Drugs Weight Management Desensitization Techniques Idiopathic Pulmonary Fibrosis Randomized Trials Weight Loss Medications TAR-200 Study CLEVER Trial Biomarkers SunRISe-1 Trial IDeate-Lung01 Trial Ibezapolstat Efficacy Combination Therapy Gene Therapy Trials Zemcelpro Trials Immunotherapy Small Cell Lung Cancer Phase III Trials NOBILITY Study Drug Comparison Studies CRITICS-II Trial Sorfequiline Study SOLACE2 Trial HLX-1502 Safety and Efficacy Drug Efficacy

Sorfequiline Outperforms Standard TB Regimens in Phase 2 Trial

Public-health experts urge a cautious rollout given diagnostic capacity constraints.

Perioperative Immunotherapy and Liquid Biopsy Show Promise in Resectable Mesothelioma Phase 2 Trial

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

B7-H3 ADC Ifinatamab Deruxtecan Shows 48% Response in Relapsed ES-SCLC in Phase 2

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial

EU Grants Conditional Approval to Zemcelpro for Adults Needing Transplants Without a Matched Donor

Everolimus Plus Carboplatin Delays Progression in Advanced Triple-Negative Breast Cancer, Phase 2 Study Shows

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial